SIBIA NEUROSCIENCES, INC.
DEAD

Serial Number

75081475

Owner

SIBIA Neurosciences, Inc.

Attorney

Stephanie L. Seidman

First Use Date

Feb 2, 1998

Filing Date

Apr 1, 1996

Add to watchlist:

No watchlists yet
View on USPTO

SIBIA NEUROSCIENCES, INC. Trademark

Serial Number: 75081475 • Registration: 2166270

SIBIA NEUROSCIENCES, INC. is a trademark filed by SIBIA Neurosciences, Inc. on April 1, 1996. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently no longer active.

Owner Contact Info

SIBIA Neurosciences, Inc. (2 trademarks)

505 Coast Blvd. South, Suite 300
La Jolla, CA 920374641

Entity Type: 03

Trademark Details

Filing Date

April 1, 1996

Registration Date

June 16, 1998

First Use Anywhere

February 2, 1998

First Use in Commerce

February 2, 1998

Published for Opposition

August 26, 1997

Cancellation Date

March 19, 2005

Goods & Services

scientific laboratory equipment, namely, an automatic electromechanical robotic apparatus for analyzing chemical and biological syntheses, reactions and assays

pharmaceutical and veterinary preparations in the nature of biochemical agents, organic molecules and synthetic compounds, nucleotides, nucleic acids, peptides, proteins and genetically engineered solutions ad formulations for use in the treatment of attention deficit disorders, substance abuse, cardiovascular diseases, emphysema and neural and neurodegenerative disorders

biochemicals, namely, peptides, proteins, nucleotides and antibodies for scientific and research purposes; chemicals, namely, small organic molecules and synthetic organic compounds for use in laboratory research and the pharmaceutical industry; scientific or research chemicals, namely, antibodies, peptides, proteins, recombinant cell lines, buffers and other reagents and solutions for in vitro diagnosis of neurodegenerative diseases; genetically engineered reagents for scientific or research use, namely, nucleic acids, plasmids, peptides, proteins, recombinant cell lines, plant seeds and non-human organisms, such as transgenic plants or animals, for use in the diagnosis and development of pharmaceutical preparations for the treatment of neurodegenerative disorders, and for the production of recombinant proteins, or assays for the identification of compounds effective against attention deficit disorders, substance abuse, cardiovascular diseases, emphysema and neural and neurodegenerative disorders

Filing History

CANCELLED SEC. 8 (6-YR)
Mar 19, 2005 C8..
REGISTERED-PRINCIPAL REGISTER
Jun 16, 1998 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 22, 1998 CNPR
ASSIGNED TO EXAMINER
Apr 21, 1998 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Apr 11, 1998 SUPC
USE AMENDMENT FILED
Mar 6, 1998 IUAF
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 18, 1997 NOAM
PUBLISHED FOR OPPOSITION
Aug 26, 1997 PUBO
NOTICE OF PUBLICATION
Jul 25, 1997 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 6, 1997 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 1997 CRFA
FINAL REFUSAL MAILED
Apr 29, 1997 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 18, 1997 CRFA
NON-FINAL ACTION MAILED
Sep 13, 1996 CNRT
ASSIGNED TO EXAMINER
Sep 3, 1996 DOCK